Top Five Global Retail Drug Companies: Performance, Strategies, and Competitive Analysis,

The global retail drug industry has grown steadily over the last five years and is expected to reach approximately US $1,420 billion in 2017 with a CAGR of 3.6% over the next five years. Direct mail advertising, television and print media advertising, telemarketing, Internet advertising and social media, as well as bundled product

and service strategies, are expected to drive industry growth.

Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the global retail drug companies and presents its findings in “Top Five Global Retail Drug Companies: Performance, Strategies, and Competitive Analysis.” The report provides detailed insight into the performance of the top five global retail drug companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.

The retail drug industry is highly diversified and includes pharmacies and drug stores, cosmetics, beauty supplies, and perfume stores, optical goods stores, other health, and personal care stores. In this study, Lucintel thoroughly profiles the following five companies with detailed competitive assessments:
 

Lucintel’s research indicates that the Asia Pacific (APAC) region depicts the best growth prospects for retailers with its increasing aging population, greater health consciousness, and consumer demand. The macroeconomic factors such as rising population and increasing disposable income of consumers are anticipated to impact market dynamics significantly. Strategic product alliances directly with industry-leading manufacturers also can help raise sales in this industry.

This study is intended to provide industry leaders with a competitive benchmarking of the world’s top five global retail drug companies. The study provides up-to-date information on the market share, profit margins, capabilities, and strategies of the leaders. The report helps current suppliers realistically assess their strengths vis-a-vis leading competitors. It is designed to provide executives with strategically significant competitor information, data analysis, and insight critical to the development and implementation of effective marketing and sales plans.

Retail drug competitive analysis report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global retail drug companies industry. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business

In Lucintel's newest competitive research study on the world's retail drug companies, we thoroughly profile following five companies with detailed competitive assessments:
 

The detailed analysis of each company offers a critical view into key strategic areas, including:
 

To make any investment, business or strategic decisions, you need adequate and timely information.Retail drug competitive analysis market report fulfills this core need. This is an indispensable reference guide for industry executives who are dealing with retail drug companies industry. 

Some of the features of Top Five Global Retail Drug Companies: Performance, Strategies, and Competitive Analysis market intelligence report are:
 

 

List of Figures

 

CHAPTER 3. Market Opportunity

Figure 3.1: Supply chain for retail drug market

Figure 3.2: Global retail drug industry annual trend 2006-2011 (US $B)

Figure 3.3: Global retail drug industry regional trend 2006-2011 (US $B)

Figure 3.4: Global retail drug industry regional trend 2006-2011 (%)

Figure 3.5: Global retail drug industry segment trend 2006-2011 (US $B)

Figure 3.6: Global retail drug industry segment trend 2006-2011 (%)

Figure 3.7: Global retail drug industry opportunity by region

Figure 3.8: Global retail drug industry opportunity by segment

    

CHAPTER 4. Competitive Benchmarking (Financial and Market)

Figure 4.1: Top five retail drug companies – financial benchmarking

Figure 4.2: Global top five retail drug companies gross profit and net profit analysis – 2011

Figure 4.3: Financial analysis – growth leadership quadrant (2011)

Figure 4.4: Market share of top players 2006

Figure 4.5: Market share of top players 2011

Figure 4.6: 2006 Market share analysis 2011

Figure 4.7: 2011 Market share analysis 2011

Figure 4.8: Global market share analysis 2011

Figure 4.9: Global market fragmentation 2011  

Figure 4.10: Market value North America: (US $B)

Figure 4.11: Market value Europe: (US $B)

Figure 4.12: Market value Asia Pacific: (US $B)

Figure 4.13: Market value Row: (US $B)

Figure 4.14: Regional revenue evaluation 2011(US $B)

Figure 4.15: Regional revenue evaluation 2011(%)

Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)

Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)

Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)

Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)

Figure 4.20: Lucintel triad - top five major players

 

CHAPTER 5. Company Profile of CVS Caremark

Figure 5.1: CVS Caremark’s revenue by business structure 2011

Figure 5.2: Lucintel Triad – CVS Caremark’s

Figure 5.3: Financial benchmarking CVS Caremark’s against top three and top five industry players’ average

Figure 5.4: Financial benchmarking of CVS Caremark’s against top five best

Figure 5.5: Global industry revenue trend Vs CVS Caremark’s (2007-2011) in US $B

Figure 5.6: Global market share trend for CVS Caremark’s (2007-2011) in (%)

Figure 5.7: North American industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)

Figure 5.8: European industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)

Figure 5.9:   APAC industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)

Figure 5.10: ROW industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)

Figure 5.11: North American market share trend Vs CVS Caremark’s 2007-2011 in (%)

Figure 5.12: European market share trend Vs CVS Caremark’s 2007-2011 in (%)

Figure 5.13: APAC market share trend Vs CVS Caremark’s 2007-2011 in (%)

Figure 5.14: ROW market share trend Vs CVS Caremark’s 2007-2011 in (%)

Figure 5.15: CVS Caremark’s productivity: 2007-2011 in (US $B)

Figure 5.16: CVS Caremark’s fixed asset value: 2007-2011 in (US $B)

Figure 5.17: Strategic execution

 

CHAPTER 6. Company Profile of Rite Aid

Figure 6.1: Rite Aid revenue by business structure 2011

Figure 6.2: Lucintel triad - Rite Aid

Figure 6.3: Financial benchmarking of Rite Aid against top three and top five industry players’ average

Figure 6.4: Financial benchmarking of Rite Aid against Top five best

Figure 6.5: Global industry revenue trend Vs Rite Aid (2007-2011) in (US $B)

Figure 6.6: Global market share trend for Rite Aid. (2007-2011) in (%)

Figure 6.7: North American industry revenue trend Vs Rite Aid. 2007-2011 in (US $B)

Figure 6.8: European industry revenue trend Vs Rite Aid. 2007-2011 in (US $B)

Figure 6.9: APAC industry revenue trend Vs Rite Aid. 2007-2011 in (US $B)

Figure 6.10: ROW industry revenue trend Vs Rite Aid 2007-2011 in (US $B)

Figure 6.11: North American market share trend Vs Rite Aid. 2007-2011 in (%)

Figure 6.12: European market share trend Vs Rite Aid. 2007-2011 in (%)

Figure 6.13: APAC market share trend Vs Rite Aid. 2007-2011 in (%)

Figure 6.14: ROW market share trend Vs Rite Aid. 2007-2011 in (%)

Figure 6.15: Rite Aid productivity: 2007-2011 in (US $B)

Figure 6.16: Rite Aid fixed asset value: 2007-2011 in (US $B)

Figure 6.17: Strategic execution

 

CHAPTER 7. Company Profile of Target Corp.  

Figure 7.1: Target Corp. revenue by business structure 2011

Figure 7.2: Lucintel triad – Target Corp.

Figure 7.3: Financial benchmarking of Target Corp. against top three and top five industry players’ average

Figure 7.4: Financial benchmarking of Target Corp. against Top five best

Figure 7.5: Global industry revenue trend Vs Target Corp. (2007-2011) in (US $B)

Figure 7.6: Global market share trend for Target Corp. (2007-2011) in (%)

Figure 7.7: North American industry revenue trend Vs Target Corp. (2007-2011) in (US $B)

Figure 7.8: European industry revenue trend Vs Target Corp. (2007-2011) in (US $B)

Figure 7.9: APAC industry revenue trend Vs Target Corp. (2007-2011) in (US $B)

Figure 7.10: ROW industry revenue trend Vs Target Corp. (2007-2011) in (US $B)

Figure 7.11: North American market share trend Vs Target Corp. (2007-2011) in (%)

Figure 7.12: European market share trend Vs Target Corp. (2007-2011) in (%)

Figure 7.13: APAC market share trend Vs Target Corp. (2007-2011) in (%)

Figure 7.14: ROW market share trend Vs Target Corp. (2007-2011) in (%)

Figure 7.15: Target Corp. productivity: 2007-2011 in (US $B)

Figure 7.16: Target Corp. fixed asset value: 2007-2011 in (US $B)

Figure 7.17: Strategic execution

 

CHAPTER 8. Company Profile of Walgreens

Figure 8.1: Walgreens revenue by business structure 2011

Figure 8.2: Lucintel triad – Walgreens

Figure 8.3: Financial benchmarking of Walgreens against top three and top five industry players’ average

Figure 8.4: Financial benchmarking of Walgreens against Top five best

Figure 8.5: Global industry revenue trend Vs Walgreens (2007-2011) in (US $B)

Figure 8.6: Global market share trend for Walgreens (2007-2011) in (%)

Figure 8.7: North American industry revenue trend Vs Walgreens (2007-2011) in (US $B)

Figure 8.8: European industry revenue trend